Finance

Beta
Lists
603367:SHA
Cisen Pharmaceutical Co Ltd
CNÂ¥13.46
+1.13%
(+0.15) 1D
Jun 5, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603367...
Open
CNÂ¥13.41
High
CNÂ¥13.60
Low
CNÂ¥13.37
Mkt. cap
6.09B
Avg. vol.
5.76M
Volume
3.95M
Dividend
2.59%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 3, 2026
P/E ratio
14.92
52-wk high
CNÂ¥35.20
52-wk low
CNÂ¥13.23
EPS
CNÂ¥0.90
Shares outstanding
453.35M
No. of employees
3K
Open
CNÂ¥13.41
High
CNÂ¥13.60
Low
CNÂ¥13.37
Mkt. cap
6.09B
Avg. vol.
5.76M
Volume
3.95M
Dividend
2.59%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 3, 2026
P/E ratio
14.92
52-wk high
CNÂ¥35.20
52-wk low
CNÂ¥13.23
EPS
CNÂ¥0.90
Shares outstanding
453.35M
No. of employees
3K
News stories
From sources across the web
About Cisen Pharmaceutical Co Ltd
CEO-
Employees3.11K
Founded1970
Headquarters-
SectorPharmaceutical industry
Websitecisen-pharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
819.57M
844.01M
860.94M
850.35M
Cost of goods sold
445.46M
344.42M
573.36M
357.36M
Cost of revenue
445.46M
344.42M
573.36M
357.36M
Research and development expenses
72.32M
75.11M
64.71M
61.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
274.58M
265.28M
282.36M
264.11M
Operating expense
355.56M
347.39M
350.37M
342.09M
Total operating expenses
801.02M
691.82M
923.73M
699.45M
Operating income
18.55M
152.19M
-62.79M
150.90M
Other non operating income
-196.17K
-2.09M
2.84M
-2.77M
EBT including unusual items
96.43M
166.86M
72.88M
143.85M
EBT excluding unusual items
32.45M
221.28M
-25.12M
183.29M
Income tax expense
9.75M
12.91M
32.51M
11.74M
Effective tax rate
10.11%
7.74%
44.60%
8.16%
Other operating expenses
8.46M
4.99M
8.66M
8.47M
Net income
85.61M
152.86M
39.24M
130.75M
Net profit margin
10.45%
18.11%
4.56%
15.38%
Earnings per share
-
-
-
-
Interest and investment income
14.57M
71.11M
36.47M
35.23M
Interest expense
-412.35K
-
-847.99K
-66.59K
Net interest expenses
14.16M
71.11M
35.62M
35.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
62.96M
206.30M
-13.96M
199.73M
Gain or loss from assets sale
-419.69K
419.69K
707.42K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer